Myriad's impact on gene patents

Nature Biotechnology

Volumn 34, Issue 11, 2016, Pages 1119-1123

  Aboy, Mateo ^a,b   Liddell, Kathleen ^a   Liddicoat, Johnathon ^a   Crespo, Cristina ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b OREGON INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; COMPLEMENTARY DNA; GENOMIC DNA; SINGLE STRANDED DNA; SYNTHETIC DNA;

ARTICLE; CITATION ANALYSIS; DNA SEQUENCE; EMPIRICISM; GENE; GENE MUTATION; GENETIC CODE; GENETICS; HUMAN; INVENTOR; LANDSCAPING; NONHUMAN; ORGANIZATION AND MANAGEMENT; PATENT; PRIORITY JOURNAL; PUBLICATION; REPRODUCIBILITY; ALGORITHM; DRUG INDUSTRY; JURISPRUDENCE; LEGISLATION AND JURISPRUDENCE; UNITED STATES;

ALGORITHMS; DRUG INDUSTRY; GENES; PATENTS AS TOPIC; PUBLICATIONS; SUPREME COURT DECISIONS; UNITED STATES;

EID: 84994910791     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt.3719     Document Type: Article

References (24)

1. Association for Molecular Pathology v. Myriad Genetics, Inc., 133 S. Ct. 2107 (2013).
2. Burk, D.L. J. Law Biosci. 2, 606-626 (2015).
3. In re BRCA1-& BRCA2-Based Hereditary Cancer Test Patent Litig v. Ambry Genetics Corp., 774 F.3d 755 (Fed. Cir. 2014).
4. Sherkow, J.S. & Greely, H.T. Annu. Rev. Genet. 49, 161-182 (2015).
5. Guerrini, C.J., Majumder, M.A. & McGuire, A.L. Nat. Biotechnol. 34, 145-147 (2016).
6. Graff, G.D. et al. Nat. Biotechnol. 31, 404-410 (2013).
7. Gordon, J. Cold Spring Harb. Perspect. Med. 5, http://dx.doi.org/10.1101/cshperspect.a020917 (2014).
8. Cook-Deegan, R. & Niehaus, A. Curr. Genet. Med. Rep. 2, 223-241 (2014).
9. Woessner, W.D. & Chadwick, R.A. Pharm. Pat. Anal. 2, 165-167 (2013).
10. Ratner, M. Nat. Biotechnol. 31, 663-665 (2013).
11. Gold, R.E., Cook-Deegan, R. & Bubela, T. Sci. Transl. Med. 5, 192ed9 (2013).
12. Offit, K. et al. J. Clin. Oncol. 31, 2743-2748 (2013).
13. Bubela, T. et al. Nat. Biotechnol. 31, 202-206 (2013).
14. Cook-Deegan, R. & Heaney, C. Annu. Rev. Genomics Hum. Genet. 11, 383-425 (2010).
15. Hopkins, M.M., Mahdi, S., Patel, P. & Thomas, S.M. Nat. Biotechnol. 25, 185-187 (2007).
16. 35 USC § 101.
17. 35 USC § 102.
18. 35 USC § 103.
19. Mayo Collaborative Services v. Prometheus Laboratories, Inc., 132 S. Ct. 1289 (2012).
20. Alice Corporation v. CLS Bank International, 132 S. Ct. 2347 (2014).
21. Arora, A., Fosfuri, A. & Gambardella, A. Markets for Technology (MIT Press, 2001).
22. Sichelman, T. & Graham, S.J. Mich. Telecomm. & Tech. L. Rev. 17, 111-180 (2010).
23. http://www.scotusblog.com/case-files/cases/association-for-molecular-pathology-v-myriad-genetics-inc/
24. Royzman, I. Nat. Biotechnol. 33, 925-926 (2015).